Latest Financials News

FAR Limited reported a sharp turnaround to a $1.8 million loss in H1 2025, driven by a $6 million claim from Woodside Energy over its Senegal RSSD Project sale. The company continues negotiations amid volatile oil prices impacting its receivables.

An independent in vivo study from the University of South Florida reveals ArtemiC™ significantly boosts survival and reduces inflammation in a severe viral model, reinforcing its promise as a novel immunomodulatory therapy.

Regal Partners reports a 48% drop in statutory profit for H1 2025 despite growing funds under management to $17.7 billion, while strategically expanding into hotel real estate with the Mayfair Hotel acquisition.

EVT Group reported a 6.3% rise in normalised EBITDA to $160.8 million for FY25, led by record Hotels performance and resilient Entertainment results despite film supply challenges. The company declared a fully franked final dividend of 22 cents per share.

Neuren Pharmaceuticals has initiated the first US investigational site for its pivotal Phase 3 trial of NNZ-2591 targeting Phelan-McDermid syndrome, marking a significant milestone in addressing this rare neurodevelopmental disorder.

Santos Limited reported robust first-half 2025 results, underpinned by strong cash flow and disciplined cost management, while accelerating the start-up of its Pikka phase 1 project to early 2026. The company declared a higher interim dividend, reflecting confidence in its growth trajectory.

Close the Loop Limited reported a challenging FY25 with significant declines in earnings and cash flow, driven by shifts in its IT asset disposition business. The company has responded with new leadership appointments and a strategic five-pillar plan aimed at restoring growth and operational efficiency in FY26.

Santos Limited reports a 31% drop in net profit for H1 2025 despite increased sales volumes and progress on key projects, while receiving a non-binding acquisition proposal from an Abu Dhabi-led consortium.

Close the Loop Limited reported a 7% decline in revenue to $195.1 million for FY25, alongside a significant net loss increase to $21.9 million, driven by operational challenges and one-off costs. The company is navigating leadership changes and portfolio adjustments while maintaining a focus on sustainability and circular economy growth.

Tasmea Limited has reported a robust FY25 with a record $600 million order book for FY26, underpinning a confident earnings outlook. The company’s strategic acquisitions and strong organic growth fuel a 32% NPAT increase forecast for FY26.

Santos Limited has agreed to extend exclusivity with the XRG Consortium, led by Abu Dhabi National Oil Company, to finalize due diligence and progress a potential US$5.76 per share acquisition. The consortium remains committed, but the deal’s completion is still uncertain.

EVT Limited reported solid full-year FY25 results with revenue and profit growth, driven by record hotel performance and a recovering entertainment division. The group signals confidence with a strong dividend and optimistic FY26 outlook.